Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K L Marek

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Movement Disorders : Official Journal of the Movement Disorder Society|May 29, 1999
Effect of treatment with L-dopa/carbidopa or L-selegiline on striatal dopamine transporter SPECT imaging with [123I]beta-CITR B Innis, K L Marek, K Sheff, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 1, 1993
Synaptotagmin: a membrane constituent of neuropeptide-containing large dense-core vesiclesC Walch-Solimena, K Takei, K L Marek, et al.
Experimental Neurology|November 5, 2003
Assessment of neuroimaging techniques as biomarkers of the progression of Parkinson's diseaseD J Brooks, K A Frey, K L Marek, et al.
Archives of Neurology|August 26, 1998
Randomized, placebo-controlled study of tolcapone in patients with fluctuating Parkinson disease treated with levodopa-carbidopa. Tolcapone Fluctuator Study Group IIIC H Adler, C Singer, C O'Brien, et al.
The New England Journal of Medicine|November 26, 1992
Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's diseaseD D Spencer, R J Robbins, F Naftolin, et al.
Archives of Neurology|July 1, 1995
General cognitive ability following unilateral and bilateral fetal ventral mesencephalic tissue transplantation for treatment of Parkinson's diseaseK J Sass, C P Buchanan, M Westerveld, et al.
Biological Psychiatry|October 15, 1995
Psychiatric status after human fetal mesencephalic tissue transplantation in Parkinson's diseaseL H Price, D D Spencer, K L Marek, et al.
Annals of the New York Academy of Sciences|September 24, 1993
Neural transplantation for neurodegenerative diseases: past, present, and futureD E Redmond, R H Roth, D D Spencer, et al.
Annals of Neurology|October 1, 1995
Decreased single-photon emission computed tomographic [123I]beta-CIT striatal uptake correlates with symptom severity in Parkinson's diseaseJ P Seibyl, K L Marek, D Quinlan, et al.
Neurology|January 1, 1996
[123I] beta-CIT/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's diseaseK L Marek, J P Seibyl, S S Zoghbi, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Movement Disorders : Official Journal of the Movement Disorder Society|May 29, 1999
Effect of treatment with L-dopa/carbidopa or L-selegiline on striatal dopamine transporter SPECT imaging with [123I]beta-CITR B Innis, K L Marek, K Sheff, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 1, 1993
Synaptotagmin: a membrane constituent of neuropeptide-containing large dense-core vesiclesC Walch-Solimena, K Takei, K L Marek, et al.
Experimental Neurology|November 5, 2003
Assessment of neuroimaging techniques as biomarkers of the progression of Parkinson's diseaseD J Brooks, K A Frey, K L Marek, et al.
Archives of Neurology|August 26, 1998
Randomized, placebo-controlled study of tolcapone in patients with fluctuating Parkinson disease treated with levodopa-carbidopa. Tolcapone Fluctuator Study Group IIIC H Adler, C Singer, C O'Brien, et al.
The New England Journal of Medicine|November 26, 1992
Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's diseaseD D Spencer, R J Robbins, F Naftolin, et al.
Archives of Neurology|July 1, 1995
General cognitive ability following unilateral and bilateral fetal ventral mesencephalic tissue transplantation for treatment of Parkinson's diseaseK J Sass, C P Buchanan, M Westerveld, et al.
Biological Psychiatry|October 15, 1995
Psychiatric status after human fetal mesencephalic tissue transplantation in Parkinson's diseaseL H Price, D D Spencer, K L Marek, et al.
Annals of the New York Academy of Sciences|September 24, 1993
Neural transplantation for neurodegenerative diseases: past, present, and futureD E Redmond, R H Roth, D D Spencer, et al.
Annals of Neurology|October 1, 1995
Decreased single-photon emission computed tomographic [123I]beta-CIT striatal uptake correlates with symptom severity in Parkinson's diseaseJ P Seibyl, K L Marek, D Quinlan, et al.
Neurology|January 1, 1996
[123I] beta-CIT/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's diseaseK L Marek, J P Seibyl, S S Zoghbi, et al.
Pageof 2